MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 36 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,483 | -65.3% | 97,100 | -12.1% | 0.00% | – |
| Q2 2023 | $165,609 | -15.4% | 110,406 | -3.0% | 0.00% | – |
| Q1 2023 | $195,846 | +15.0% | 113,864 | -23.1% | 0.00% | – |
| Q4 2022 | $170,283 | -55.1% | 148,072 | +2.0% | 0.00% | – |
| Q3 2022 | $379,000 | +952.8% | 145,114 | +773.2% | 0.00% | – |
| Q2 2022 | $36,000 | -82.0% | 16,618 | -61.2% | 0.00% | – |
| Q1 2022 | $200,000 | -48.2% | 42,871 | -32.6% | 0.00% | – |
| Q4 2021 | $386,000 | +51.4% | 63,630 | +79.0% | 0.00% | – |
| Q3 2021 | $255,000 | +87.5% | 35,550 | +65.0% | 0.00% | – |
| Q2 2021 | $136,000 | – | 21,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |